An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). [electronic resource]
Producer: 20101213Description: 1169-73 p. digitalISSN:- 1434-9949
- Adolescent
- Adult
- Aged
- Antirheumatic Agents -- adverse effects
- Arthritis, Psoriatic -- drug therapy
- Drug Therapy, Combination
- Female
- Humans
- Intention to Treat Analysis
- Interleukin 1 Receptor Antagonist Protein -- adverse effects
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Pilot Projects
- Prospective Studies
- Severity of Illness Index
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.